Colchicine and indomethacin for the treatment of relapsing polychondritis

Mark, Kenneth A. MD
Franks, Andrew G. Jr MD

New York, New York
From the Connective Tissue Section of the Charles C. Harris Skin and Cancer Pavilion, The Ronald O. Perelman Department of Dermatology, New York University School of Medicine.

This supplement is made possible through an unrestricted educational grant from Stiefel Laboratories to the American Academy of Dermatology.

Reprint requests: Andrew G. Franks, Jr, MD, Department of Dermatology, 560 1st Ave, Ste H100, New York, NY 10016.

0190-9622/2002/$35.00 + 0 16/4/105477

doi:10.1067/mjd.2002.105477

Journal of the American Academy of Dermatology 46(2):p S22-S24, February 2002.

This report describes the effectiveness of oral colchicine and indomethacin in the maintenance phase of treatment of relapsing polychondritis. Systemic corticosteroids are commonly used in the induction phase of managing cases of relapsing polychondritis. Clinicians are then faced with the challenge of controlling the patient's symptoms while trying to decrease the dose of steroid. (J Am Acad Dermatol 2002;46:S22-4.)